Latest filing published 27 Dec 2022 for ABIOMED INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Myron L. Rolle: trading record in brief
Myron L. Rolle, listed as board member, appears in our data through filings on Abiomed Inc shares, published by SEC (Form 4). We count 6 filings; the first trade dates from 17 February 2021 and the latest from 22 December 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 27 December 2022 came the latest disclosure, a transaction in Abiomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Myron L. Rolle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,721 shares0Common Stock, $.01 par valueSEC:0001415889-22-012998:0
- 681 shares0Common Stock, $.01 par valueSEC:0001415889-22-008529:0
- 112 shares@ US$325.42100.0% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-001486:0
- 625 shares0Common Stock, $0.01 par valueSEC:0001179110-21-008174:0
4 of 4 declarations
